Picornaviruses represent an important group of viral pathogens that have been identified in numerous reptile species, causing a range of clinical presentations from subclinical infection to severe systemic disease. These small RNA viruses belong to the family Picornaviridae, which also includes significant pathogens of humans and other mammals. In reptiles, picornaviruses have been associated primarily with gastrointestinal disease and hepatic involvement, though the full spectrum of disease caused by these viruses continues to be characterized as research advances. The recognition of picornaviruses as reptile pathogens has grown considerably in recent years with improved molecular diagnostic capabilities.
Picornavirus infections have been documented across diverse reptile groups, with chelonians including tortoises and turtles appearing particularly susceptible to certain strains. Various tortoise species have experienced outbreaks attributed to picornaviruses, sometimes with significant mortality rates in affected collections. The virus has also been identified in numerous lizard species and occasional snake infections have been reported. The true prevalence of picornavirus infection in captive and wild reptile populations is likely underestimated, as many infections may be subclinical or misattributed to other causes without specific viral testing.
The health impact of picornavirus infection in reptiles varies considerably depending on the viral strain, host species, and the animal's overall immune status. Some infections cause primarily gastrointestinal disease with enteritis, diarrhea, and failure to thrive. Hepatic involvement may occur, potentially leading to liver damage and associated metabolic disturbances. In severe cases, systemic infection can develop with multiorgan involvement and high mortality rates. The temperature-dependent nature of reptile immunity means that animals maintained at suboptimal temperatures may be unable to mount effective responses against picornavirus infection, leading to more severe disease outcomes.
While no specific antiviral treatments exist for reptile picornaviruses, supportive care and optimal husbandry can help affected animals survive and recover. Early recognition of infection allows for prompt implementation of supportive measures and isolation to prevent spread to other animals. Prevention through quarantine protocols and maintaining strong immune function through proper husbandry represents the most effective approach to managing this viral threat. Any reptile suspected of having picornavirus infection should be evaluated by a reptile-experienced veterinarian who can confirm the diagnosis and develop an appropriate treatment and management plan.
